✦ LIBER ✦

Treatment of multiple myeloma with recombinant interferon alfa-2a

✍ Scribed by Ryuzo Ohno; Kiyoji Kimura

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 459 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860415)57:8+<1685::aid-cncr2820571310>3.0.co;2-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of carcinoma of the esophagus

Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon

✍ Scott Wadler; Stanley Fell; Hilda Haynes; Henry J. Katz; Alla Rozenblit; Ronald 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 1 views

Clinical studies of recombinant interfer

Clinical studies of recombinant interferon alfa-2a (Roferon®-A) in cancer patients

✍ Tetsuo Taguchi 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

A Phase I study of interferon alfa-2a was conducted in 20 patients with disseminated cancer to establish the relationship between dose and interferon-related side effects. Fever was the most common side effect, and was not doserelated. Other side effects not related to dose included flu-like symptom

Phase II trial of recombinant interferon

Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis

✍ Dr. Morie A. Gertz; Robert A. Kyle 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

A phase I study of subcutaneous recombin

A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a

✍ Mark J. Ratain; Edwin R. Priest; Linda Janisch; Nicholas J. Vogelzang 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

Background. Both recombinant in1 erferon alfa and interleukin-2 (IL-2) have been shown to lave some activity as single agents in metastatic renal cj !I1 cancer (RCC), although their activity is minimal in mo -e common solid tumors. Recent preclinical studies hav ? suggested that the combination of t

Acute and definitive renal failure in pr

Acute and definitive renal failure in progressive multiple myeloma treated with recombinant interferon alpha-2a: Report on two patients

✍ C. Noël; F. Vrtovsnik; T. Facon; M. P. Noël-Walter; M. Hazzan; J. P. Jouet; F. B 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 2 views

Relief of intractable pruritus in polycy

Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa

✍ Dr. Carlo Finelli; Luigi Gugliotta; Barbara Gamberi; Nicola Vianelli; Giuseppe V 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Following reports that recombinant interferon alfa (rlFNu), besides inducing clinical and hematologic remission in polycythemia Vera (PV), can also resolve intractable pruritus, we used rlFNu to treat 13 PV patients complaining of severe pruritus refractory to conventional treatment (venesection and